Gastrointest Endosc 40(1):79 Olsen JC, McGrath NA, Schwarz DG, Cutcliffe BJ, Stern JL (2008) A double-blind randomized clinical trial evaluating the analgesic efficacy of ketorolac versus butorphanol for patients with suspected biliary colic in the emergency department
Its Wednesday June 3 rd at 2 pm in New York
A key reason for the success of its Zepbound drug is its status as a "dual agonist." Wegovy targets only GLP-1 receptors, whereas tirzepatide (aka Zebound) targets both GLP-1 and GIP receptors, leading to greater overall weight loss
This direct delivery makes B12 shots especially beneficial for individuals experiencing mental fatigue, chronic stress, or mood fluctuations
The lack of human data means we are extrapolating safety from horses to humans, a leap that rarely holds up perfectly in clinical practice